drugset / Trial / NCT00035243
EPO906 Therapy in Patients With Advanced Kidney Cancer
Non-randomizedSingle-groupOpen-labelTreatment
Summary
This study will examine whether the investigational drug EPO906, given by intravenous infusion (IV directly into the vein), is effective in shrinking tumors and preventing the growth of cells that cause kidney cancer.
Timeline
- Start
- 2002-04
- Primary completion
- 2003-08
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Patupilone | Small molecule | 2.5 mg/m2 | Intravenous |